Before you sell to, join or invest in Etheros Pharmaceuticals Corp.
MentionFox check on Etheros Pharmaceuticals Corp.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/etheros-pharmaceuticals-corp-form-d-25000001
Check Etheros Pharmaceuticals Corp. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Etheros Pharmaceuticals Corp.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Etheros Pharmaceuticals Corp. filed a Form D with the Securities and Exchange Commission on 2025-06-10.
Etheros Pharmaceuticals Corp. filed a Form D notice of an exempt securities offering with the SEC on June 10, 2025. The filing reports $600K sold. Its industry group is Pharmaceuticals. It names John Scannell (Executive Officer, Director), Marc Feldmann (Director), Laura Dugan (Director) (SEC Form D, June 10, 2025).
Is this your company?
Sell to companies like Etheros Pharmaceuticals Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-06-10 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Etheros Pharmaceuticals Corp.
Free to see. No signup.
More on the people and the money behind Etheros Pharmaceuticals Corp., from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when Etheros Pharmaceuticals Corp. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Etheros Pharmaceuticals Corp. raises, hires or launches. No email unless you switch it on.
Watch Etheros Pharmaceuticals Corp. →Get the full cited report on Etheros Pharmaceuticals Corp.
What the filing shows about Etheros Pharmaceuticals Corp.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Etheros Pharmaceuticals Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Etheros Pharmaceuticals Corp.'s address as 111 10TH Ave S, Ste 110, Nashville, TN 37203.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Etheros Pharmaceuticals Corp. See pricing
Etheros Pharmaceuticals Corp. is a registered filer with the SEC (CIK 2005132) and has filed since 2023-12-20. 3 filings are on record, the latest on 2025-06-10.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Etheros Pharmaceuticals Corp.'s Form D of 2025-06-10 names John Scannell, Marc Feldmann, Laura Dugan and 2 more as its officers, directors or promoters.
Its new offerings report $1.68M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
May be paid to a director who provides consulting services to the company.
John Scannell is named as Executive Officer and Director on the Form D that Etheros Pharmaceuticals Corp. filed with the SEC on 10 June 2025, one of 5 people that filing names.
Marc Feldmann is named as Director on the Form D that Etheros Pharmaceuticals Corp. filed with the SEC on 10 June 2025, one of 5 people that filing names.
Laura Dugan is named as Director on the Form D that Etheros Pharmaceuticals Corp. filed with the SEC on 10 June 2025, one of 5 people that filing names.
Francis Knuettel II is named as Director on the Form D that Etheros Pharmaceuticals Corp. filed with the SEC on 10 June 2025, one of 5 people that filing names.
Subhasish Chakraborty is named as Executive Officer on the Form D that Etheros Pharmaceuticals Corp. filed with the SEC on 10 June 2025, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2025-06-10 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Etheros Pharmaceuticals Corp.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Etheros Pharmaceuticals Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Etheros Pharmaceuticals Corp. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Etheros Pharmaceuticals Corp.You get an alert in MentionFox the next time this company shows up.
If you're behind Etheros Pharmaceuticals Corp.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Etheros Pharmaceuticals Corp.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/etheros-pharmaceuticals-corp-form-d-25000001